ERBB2 and breast carcinoma: Treatments for HER2-positive breast cancer include chemotherapy, endocrine therapy, tyrosine kinase receptor inhibitors (TKIs) like lapatinib, and anti-HER-2 therapy like trastuzumab [5, 6].